Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
AORT - Artivion, Inc.
Market Cap 698.15M P/E - EPS this Y 66.70% Ern Qtrly Grth -
Income -30.57M Forward P/E - EPS next Y 188.00% 50D Avg Chg 7.00%
Sales 354M PEG -40.42 EPS past 5Y -6.10% 200D Avg Chg 26.00%
Dividend N/A Price/Book 2.49 EPS next 5Y 2.00% 52W High Chg -27.00%
Recommedations 1.40 Quick Ratio 2.30 Shares Outstanding 41.71M 52W Low Chg 77.00%
Insider Own 5.46% ROA 1.21% Shares Float 34.32M Beta 1.67
Inst Own 88.32% ROE -10.84% Shares Shorted/Prior 2.84M/2.69M Price 17.08
Gross Margin 64.74% Profit Margin -8.67% Avg. Volume 168,491 Target Price 24.08
Oper. Margin 5.17% Earnings Date May 6 Volume 88,784 Change -0.99%
Healthcare | Medical Devices | United States
About Artivion, Inc.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Artivion, Inc. News
04/22/24 Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
04/19/24 Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year
04/15/24 Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
04/01/24 Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/28/24 Are Medical Stocks Lagging Artivion (AORT) This Year?
03/12/24 Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?
03/06/24 Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
02/22/24 Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
02/21/24 Wall Street Analysts Think Artivion (AORT) Could Surge 30.7%: Read This Before Placing a Bet
02/15/24 Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
02/01/24 Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
01/29/24 Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
01/18/24 Artivion Obtains $350 Million in Senior Secured Credit Facilities
12/06/23 Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer
11/09/23 Artivion Announces Completion of Enrollment in PERSEVERE Trial
11/08/23 Artivion to Participate in Upcoming Investor Conferences
11/02/23 Artivion Reports Third Quarter 2023 Financial Results
10/19/23 Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
10/05/23 Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin
10/05/23 Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting
AORT Chatroom

User Image Stock_Titan Posted - 1 day ago

$AORT Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results https://www.stocktitan.net/news/AORT/artivion-announces-release-date-and-teleconference-call-details-for-vzvzrj3qtou1.html

User Image Stock_Titan Posted - 3 weeks ago

$AORT Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/AORT/artivion-to-participate-in-the-23rd-annual-needham-virtual-2xgkv99v86sm.html

User Image Doozio Posted - 03/27/24

$AORT 🧠⏰ appears to be…

User Image insiderbuyingselling Posted - 1 month ago

$AORT new insider selling: 2183 shares. http://insiderbuyingselling.com/?t=AORT

User Image insiderbuyingselling Posted - 1 month ago

$AORT new insider selling: 1462 shares. http://insiderbuyingselling.com/?t=AORT

User Image insiderbuyingselling Posted - 1 month ago

$AORT new insider selling: 2022 shares. http://insiderbuyingselling.com/?t=AORT

User Image insiderbuyingselling Posted - 1 month ago

$AORT new insider selling: 5000 shares. http://insiderbuyingselling.com/?t=AORT

User Image insiderbuyingselling Posted - 1 month ago

$AORT new insider selling: 30836 shares. http://insiderbuyingselling.com/?t=AORT

User Image insiderbuyingselling Posted - 1 month ago

$AORT new insider selling: 1157 shares. http://insiderbuyingselling.com/?t=AORT

User Image Stock_Titan Posted - 1 month ago

$AORT Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference https://www.stocktitan.net/news/AORT/artivion-to-participate-in-the-oppenheimer-34th-annual-healthcare-txrs8p7qrzf4.html

User Image insiderbuyingselling Posted - 02/29/24

$AORT new insider selling: 325 shares. http://insiderbuyingselling.com/?t=AORT

User Image TickerDD_com Posted - 02/26/24

From 2/23/2024, looking back across 22 Month-Ends for AORT, Percentage Change of Average Monthly Price had More Positives (59%) while Percentage Change of Average Monthly Volume had More Positives (95%) $AORT #AORT #AORTStock #TickerDD #AORTPrice https://www.youtube.com/watch?v=2S9D25BQEAQ

User Image Doozio Posted - 02/25/24

$AORT chop chop huckleberries 🧠⏰. Dips appear a 🎁

User Image DonCorleone77 Posted - 2 months ago

$AORT Artivion sees FY24 revenue $382M-$396M, consensus $384.26M Representing growth of 8% to 12% compared to 2023 on both an as reported and constant currency basis. At current exchange rates, the company expects negligible year-over-year currency impact to revenue. Artivion expects non-GAAP adjusted EBITDA, to increase between 26% and 34% for the full year 2024 compared to 2023, resulting in non-GAAP adjusted EBITDA to be in the range of $68M-$72M in 2024.

User Image Stock_Titan Posted - 2 months ago

$AORT Artivion Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/AORT/artivion-reports-fourth-quarter-and-full-year-2023-financial-1dq82gayvrk0.html

User Image wallstreetcorruption Posted - 2 months ago

$AORT $TCMD any of these stocks have a Pdufa date? Is it too late

User Image wallstreetcorruption Posted - 2 months ago

$AORT did Tina Smith cash out? Was her drug approved. If not when is Pdufa date!?

User Image tickeron Posted - 3 months ago

This is why Hedge Funds use A.I. $AORT Stochastic Oscillator left the overbought zone. View odds of downtrend. https://srnk.us/go/4976767

User Image ChartMill Posted - 3 months ago

$AORT: Artivion Obtains $350 Million in Senior Secured Credit Facilities https://www.chartmill.com/stock/quote/AORT/news?utm_source=prnews-2024-1-18-artivion-obtains-350-million-in-senior-secured-credit-facilities&utm_medium=stocktwits&utm_campaign=pressRelease

User Image Last10K Posted - 3 months ago

$AORT just filed with the SEC a New Agreement, a New Financial Obligation and a Financial Exhibit https://last10k.com/sec-filings/AORT/0000950157-24-000061.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=AORT

User Image risenhoover Posted - 3 months ago

$AORT / Artivion files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 18, 2024 ARTIVION, INC. ( https://fintel.io/doc/sec-artivion-inc-784199-8k-2024-january-18-19740-2245?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image shortvolumes Posted - 3 months ago

2024-01-12 Short sale volume (not short interest) for $AORT is 79%. http://shortvolumes.com/?t=AORT via @shortvolumes

User Image ChartMill Posted - 3 months ago

Pocket pivot signals in $JPST, $UNP, $DOC, $CPNG and $AORT, while they also have the support from large players according to the effective volume indicator. https://www.chartmill.com/stock/stock-screener?sid=31&f=smlev20v_b_lev,smlev20v_r,p_pg10,pp_1,v1_50b200,cu_a_sm50v,der5_a_0.03,s_ppt,exch_us&v=3&timeframe=DAILY&type=CANDLES&o1=17&op1=10%252C2,16711680&i1=49&ia1=on&cl=F&months=0.05&o2=3&op2=50,255&width=720&o3=3&op3=10,65280&utm_source=large_effective_volume_+_pocket_pivot_today&utm_medium=stocktwits&utm_campaign=screen

User Image tickeron Posted - 3 months ago

If you’re trading this week, Read This! $AORT Stochastic Oscillator left the overbought zone. View odds of downtrend. https://srnk.us/go/4967106

User Image StockAutomatePro Posted - 3 months ago

$AORT The chart is pointing towards a potential rise in the stock price. We alerted the BUY signal at $17.19 and we were able to close this one with profit at $17.96 😎 See more details at StockAutomate.com

User Image UltraAlgo Posted - 3 months ago

$AORT Sell Rating based off 5 signals, 15-min chart. 💸 UltraAlgo.com https://i.redd.it/yhhi6bdcx9bc1.png

User Image quantcha Posted - 3 months ago

StockTwits Trending Alert: Trading recent interest in ARTIVION INC $AORT https://ideas.quantcha.com/?p=76327

User Image tickeron Posted - 3 months ago

A.I.dvisor made a bearish call on $AORT, netting in a 9.90% gain over 1 week https://srnk.us/go/4962732

User Image tickeron Posted - 3 months ago

A.I.dvisor made a bearish call on $AORT, netting in a 7.66% gain over 2 weeks https://srnk.us/go/4962716

User Image modified87 Posted - 3 months ago

$AORT im out no action here gla

Analyst Ratings
Needham Buy Apr 8, 24
Stifel Buy Feb 16, 24
Needham Buy Feb 16, 24
Needham Buy Dec 7, 23
Needham Buy Nov 3, 23
Needham Buy Aug 4, 23
Morgan Stanley Equal-Weight May 8, 23
Needham Buy May 5, 23
Needham Buy Feb 17, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Horton Amy VP, Chief Accounting.. VP, Chief Accounting Officer Dec 15 Sell 19 14,397 273,543 124,040 12/19/23
Horton Amy VP, Chief Accounting.. VP, Chief Accounting Officer Dec 15 Option 16.3 14,397 234,671 138,437 12/19/23
Horton Amy VP, Chief Accounting.. VP, Chief Accounting Officer Nov 27 Sell 17.34 2,101 36,431 105,599 11/29/23
GREEN ANDREW M VP Regulatory VP Regulatory Feb 23 Sell 12.94 1,747 22,606 24,102 03/01/23
Mackin James P President & CEO President & CEO Feb 23 Sell 12.94 22,630 292,832 540,052 03/01/23
Maier Dennis B SVP, Operations SVP, Operations Feb 23 Sell 12.94 2,330 30,150 48,436 03/01/23
Stanton Marshall S. SVP, Clinical & MD A.. SVP, Clinical & MD Affair Feb 23 Sell 12.94 2,337 30,241 49,321 03/01/23
Getz Matthew A VP, Human Resources VP, Human Resources Feb 23 Sell 12.94 1,600 20,704 35,128 03/01/23
Horton Amy VP, Chief Accounting.. VP, Chief Accounting Officer Feb 17 Sell 14.1 18,000 253,800 102,663 02/21/23
Horton Amy VP, Chief Accounting.. VP, Chief Accounting Officer Feb 17 Option 10.24 20,713 212,101 105,663 02/21/23
Davis John E Senior VP, Global Sa.. Senior VP, Global Sales Feb 13 Option 10.24 8,745 89,549 120,017 02/15/23
Horton Amy VP, Chief Accounting.. VP, Chief Accounting Officer Dec 14 Sell 13.57 3,226 43,777 101,950 12/16/22
Maney Rochelle L. VP, Quality VP, Quality Aug 16 Sell 22.959 7,161 164,409 12,325 08/18/22
Maier Dennis B SVP, Operations SVP, Operations Aug 09 Sell 21.62 5,762 124,574 22,807 08/10/22
Mackin James P President & CEO President & CEO Feb 09 Option 11 21,277 234,047 314,817 02/11/22
Mackin James P President & CEO President & CEO Feb 09 Sell 18 21,277 382,986 304,178 02/11/22
Mackin James P President & CEO President & CEO Feb 08 Option 11 10,638 117,018 314,816 02/10/22
Mackin James P President & CEO President & CEO Feb 08 Sell 17.75 10,638 188,824 304,178 02/10/22
SEMEDO ANTHONY B. Director Director Nov 29 Buy 17.36 15,000 260,400 19,992 11/30/21
Davis John E Senior VP, Global Sa.. Senior VP, Global Sales May 27 Option 26.24 5,402 141,748 84,638 05/27/21
Davis John E Senior VP, Global Sa.. Senior VP, Global Sales May 27 Sell 29.67 12,739 377,966 71,899 05/27/21
Maier Dennis B Vice President, Oper.. Vice President, Operations Feb 19 Option 21.55 6,630 142,876 23,211 02/19/21
Maier Dennis B Vice President, Oper.. Vice President, Operations Feb 19 Sell 24.69 7,197 177,694 16,014 02/19/21
Capps Scott B VP, Clinical Researc.. VP, Clinical Research Dec 16 Option 9.97 10,000 99,700 157,006 12/16/20
Capps Scott B VP, Clinical Researc.. VP, Clinical Research Dec 16 Sell 21.34 8,366 178,530 148,640 12/16/20
Horton Amy VP, Chief Accounting.. VP, Chief Accounting Officer Dec 16 Option 9.97 6,666 66,460 99,642 12/16/20
Horton Amy VP, Chief Accounting.. VP, Chief Accounting Officer Dec 02 Option 9.97 6,666 66,460 99,642 12/02/20
Horton Amy VP, Chief Accounting.. VP, Chief Accounting Officer Dec 02 Sell 20.78 6,666 138,519 92,976 12/02/20